DUBLIN--(BUSINESS WIRE)--The "Contrast Agents/Media Global Market - Forecast To 2027" report has been added to ResearchAndMarkets.com's offering.
According to this report the contrast agents global market is expected to grow at a high single digit CAGR from 2020 to 2027 to reach $7,033.5 million by 2027 due to the increasing incidence & prevalence of chronic diseases and demand for diagnostic & interventional radiology procedures, increase in aging population, Expansion of contrast agent indications, the growth of medical imaging in the emerging market, increasing research activities and favorable reimbursement.
Chemical substances that improve the visibility of specific organs, tissues, or blood vessels during a diagnostic or interventional imaging investigation are known as contrast agents. These substances are administered directly through veins, arteries, joints, rectally, body cavity or consumed orally. X-ray and computed tomography (CT) imaging exams make use of iodinated and barium-based contrast agents, whereas, Gadolinium-based contrast agents are preferred in MRI (Magnetic Resonance Imaging).
These substances improve the reporting or accuracy of how internal structures of the body are working and any associated abnormalities. Ultrasound scans make use of special contrast agents called microbubbles which strongly interact with the ultrasound beam and enhance the details of the heart, liver and kidney.
Market Dynamics
Drivers and Opportunities
- Increasing Demand for Diagnostic and Interventional Radiology Procedures
- Increase in Aging Population
- Expansion in Indications of Contrast Media
- Increasing Research Activities Towards the Development of Novel Contrast Agents
- The Growth of Medical Imaging Technologies in Emerging Markets
- Favorable Reimbursement
Restraints and Threats
- Side Effect Associated With Contrast Agents
- Shortage of Radiologists
- Availability of Alternative Products
- Stringent Regulations for Contrast Agents
Companies Mentioned
- Bayer Group
- Beijing Beilu Pharmaceutical Co. Ltd
- Bracco Group
- Dongkook Life Science
- Fujipharma Co Ltd
- GE Company (GE Healthcare)
- Guerbet
- Lantheus Medical Imaging Inc.
- Sanochemia Pharmaceutical AG
- Taejoon Pharm Co. Ltd
For more information about this report visit https://www.researchandmarkets.com/r/tnz73d
